Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease

International Immunology

Volumn 11, Issue 6, 1999, Pages 925-931

  Miwa, Keiko ^a   Hashimoto, Hideo ^a,b   Yatomi, Takehiro ^c   Nakamura, Norio ^c   Nagata, Shigekazu ^a,b   Suda, Takashi ^a,d  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c MOCHIDA PHARMACEUTICAL CO   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bone marrow transfer; Cytotoxic T lymphocyte; Disease model

Indexed keywords

FAS LIGAND; MONOCLONAL ANTIBODY; PERFORIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMAN; HYPOPLASIA; LETHALITY; LIVER; MONONUCLEAR CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; WEIGHT REDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CRICETINAE; CRICETULUS; FAS LIGAND PROTEIN; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 0033061656     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.6.925     Document Type: Article

References (22)

1. Kägi, D., Vagnaux, F., Ledermann, B., Bürki, K., Deraetere, V., Nagata, S., Hengartner, H. and Golstein, P. 1994. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
2. Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., Shinkai, Y., Alt, F. W., Matsuzawa, A., Yonehara, S. and Takayama, H. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357.
3. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
4. Kondo, T., Suda, T., Fukuyama, H., Adachi, M. and Nagata, S. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3:409.
5. Ferrara, J. L. and Deeg, H. J. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667.
6. Appelbaum, F. R. 1997. Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia S15.
7. Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L., Morrow, P. R. and Dixon, F. J. 1985. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med. 162:1.
8. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
9. Braun, M. Y., Lowin, B., French, L., Acha, O. H. and Tschopp, J. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
10. Baker, M. B., Altman, N. H., Podack, E. R. and Levy, R. B. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645.
11. Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S. and Suda, T. 1998. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand [in process citation]. Nat. Med. 4:1287.
12. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
13. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S. 1996. Fas ligand in human serum. Nat. Med. 2:317.
14. Suda, T. and Nagata, S. 1994. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179:873.
15. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
16. Suda, T., Tanaka, M., Miwa, K. and Nagata, S. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 157:3918.
17. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
18. Russell, J. H., Rush, B., Weaver, C. and Wang, R. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA 90:4409.
19. Alderson, M. R., Tough, T. W., Davis, S. T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
20. + T cells responding to a bacterial superantigen. J. Immunol. 154:4302.
21. Suda, T., Hashimoto, H., Tanaka, M., Ochi, T. and Nagata, S. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186:2045.
22. Tanaka, M., Itai, T., Adachi, M. and Nagata, S. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4:31.